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Effective accumulation and interaction of mature dendri-
tic cells (DCs) and naïve T cells within lymph nodes
(LNs), driven by the CCR7-CCL19/CCL21 axis, are criti-
cal for the induction of adaptive T cell immunity. Human
natural killer (NK) cells activated by IL-18 exhibit unique
‘helper’ activity in promoting productive DC-T cell inter-
actions, inducing dendritic cell (DC) maturation and the
type-1-polarization of DC-primed T cell responses. Here
we demonstrate that such IL-18-induced ‘helper’ NK
cells uniquely induce high DC production of CCL19 in a
TNFa and IFNg-mediated mechanism, dependent on
secondary NK cell stimulation with the additional inflam-
matory signals IFNa, IL-15, IL-12, or IL-2. Helper NK
cell-activated DCs promote efficient CCR7-mediated
recruitment of naïve CD8+ T cells, and subsequently
induce their expansion and acquisition of granzyme B.
Using an ex vivo explant culture system of LNs isolated
from colorectal cancer patients, we further demonstrate
enhanced expression of CCL19 in human tumor-associated
lymphoid tissue induced by treatment with helper NK
cell-stimulating factors. Our data indicate the ability of
two-signal-activated ‘helper’ NK cells to promote LN pro-
duction of the DC- and naïve/memory T cell-attracting
chemokine CCL19, and provide rationale for therapeutic
application of IL-18-containing ‘combinatorial adjuvants’ to
promote the induction of anti-tumor immunity.
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